CereVasc's Minimally Invasive Central Nervous System Therapy Delivery System Receives Outstanding Presentation Award at American Society of Gene & Cell Therapy Annual Meeting
/PRNewswire/ -- CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel treatments for neurological diseases, announced today...
Source: prnewswire.com